- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Executive Reminisces on "Green Rush" Lessons
Alison Gordon, founder and ex-CEO of a publicly traded cannabis company, shares her perspective on pressures in the Canadian cannabis market as interest in the US rises.
Against the backdrop of the Lift Expo's return, a business leader in the Canadian cannabis industry reflected on how much the industry at large has changed since the last time this event took place.
Alison Gordon was the CEO of 48North Cannabis up until the boutique cannabis company was acquired earlier this year by a fellow operator, HEXO (NASDAQ:HEXO,TSX:HEXO).
Gordon, who also founded 48North, may no longer be focused on the day-to-day duties of a licensed producer, but that doesn’t mean she’s out of the cannabis industry. Gordon has now co-founded a boutique sales agency called Other People’s Pot, which is focused on selling and distribution.
Looking back on mistakes in the Canadian cannabis market
The executive said it’s hard to pin down an accurate representation of the experience of riding the early investment wave seen in the Canadian cannabis industry. “There were a lot of mistakes made,” she said.
Gordon spoke at the business portion of the Lift Expo event, serving as a panelist in a conversation around US legalization and what lies ahead for Canadian businesses and entrepreneurs trying to expand.
“I think the legacy is: Should we have walked before we ran? ... It was this race and we figured things out. And that's laid the groundwork now for where people are going," she said.
Gordon reminisced on the difficulties of running a cannabis company while learning the ropes, a challenge she said was compounded by the lack of an established roadmap or blueprint.
US cannabis opportunity shining bright — is it right for Canadians?
When asked about the opportunity in the US, which is drawing many eyes in the cannabis industry, the executive said Canadian businesses have to be very cautious and diligent when considering the market below the border.
“There's opportunity there, but it's not an easy proposition to just go to the US and do these things,” Gordon said.
According to Gordon, the most recent MJBizCon event highlighted how far the US has come in terms of growth.
“It used to be the Canadians just dominated and you couldn't walk into the hotel without seeing 10 people you knew. It did not feel like that,” she said. “You could just see this massive growth of the US side of the industry.”
Investor takeaway
As someone who has focused so much on Canada's cannabis marketplace, Gordon didn't dismiss its its role in the industry today, even as the US moves increasingly toward center stage.
“There's a lot of benefits to being in the Canadian market. But at the same time, it's a small market, and the government's hand is heavy in it, which makes it very expensive.”
Don't forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.